231 research outputs found
A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models.
Breast cancer research is hampered by difficulties in obtaining and studying primary human breast tissue, and by the lack of in vivo preclinical models that reflect patient tumor biology accurately. To overcome these limitations, we propagated a cohort of human breast tumors grown in the epithelium-free mammary fat pad of severe combined immunodeficient (SCID)/Beige and nonobese diabetic (NOD)/SCID/IL-2γ-receptor null (NSG) mice under a series of transplant conditions. Both models yielded stably transplantable xenografts at comparably high rates (∼21% and ∼19%, respectively). Of the conditions tested, xenograft take rate was highest in the presence of a low-dose estradiol pellet. Overall, 32 stably transplantable xenograft lines were established, representing 25 unique patients. Most tumors yielding xenografts were "triple-negative" [estrogen receptor (ER)-progesterone receptor (PR)-HER2+; n = 19]. However, we established lines from 3 ER-PR-HER2+ tumors, one ER+PR-HER2-, one ER+PR+HER2-, and one "triple-positive" (ER+PR+HER2+) tumor. Serially passaged xenografts show biologic consistency with the tumor of origin, are phenotypically stable across multiple transplant generations at the histologic, transcriptomic, proteomic, and genomic levels, and show comparable treatment responses as those observed clinically. Xenografts representing 12 patients, including 2 ER+ lines, showed metastasis to the mouse lung. These models thus serve as a renewable, quality-controlled tissue resource for preclinical studies investigating treatment response and metastasis
Upper gastrointestinal Crohn's disease
Symptomatic gastroduodenal manifestations of Crohn's disease are rare, with less than 4% of patients being clinically symptomatic. Gastroduodenal involvement may, however, be found endoscopically in 20% and in up to 40% of cases histologically, most frequently as Helicobacter pylori-negative focal gastritis, usually in patients with concomitant distal ileal disease. In practice, the activity of concomitant distal Crohn's disease usually determines the indication for therapy, except in the presence of obstructive gastroduodenal symptoms. With the few data available, it seems correct to say that localized gastroduodenal disease should be treated with standard medical therapy used for more distal disease, with the exception of the galenic formulation of sulfasalazine and mesalazine with pH-dependent release. The presence of symptoms of obstruction needs aggressive therapy. If medical therapy with steroids and immunomodulatory drugs does not alleviate the symptoms, balloon dilation and surgery are the options to consider. [Ed.]]]>
oai:serval.unil.ch:BIB_5E8B8CEC2A7F
2022-05-07T01:18:50Z
openaire
documents
urnserval
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:xs="http://www.w3.org/2001/XMLSchema"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
https://serval.unil.ch/notice/serval:BIB_5E8B8CEC2A7F
Agniṣṭoma and the nature of sacrifice
Bronkhorst, Johannes
info:eu-repo/semantics/bookPart
incollection
2016
On Meaning and Mantras: Essays in Honor of Frits Staal, pp. 79-99
Thompson, George (ed.)
Payne, Richard K. (ed.)
info:eu-repo/semantics/altIdentifier/isbn/978-1-886439-64-1
eng
https://serval.unil.ch/resource/serval:BIB_5E8B8CEC2A7F.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_5E8B8CEC2A7F4
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_5E8B8CEC2A7F4
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/openAccess
Copying allowed only for non-profit organizations
https://serval.unil.ch/disclaimer
application/pdf
oai:serval.unil.ch:BIB_5E8C17A3E220
2022-05-07T01:18:50Z
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:xs="http://www.w3.org/2001/XMLSchema"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
https://serval.unil.ch/notice/serval:BIB_5E8C17A3E220
Selective regulation of acid-sensing ion channel 1 by serine proteases.
info:doi:10.1074/jbc.M407381200
info:eu-repo/semantics/altIdentifier/doi/10.1074/jbc.M407381200
info:eu-repo/semantics/altIdentifier/pmid/15247234
Poirot, O.
Vukicevic, M.
Boesch, A.
Kellenberger, S.
info:eu-repo/semantics/article
article
2004
Journal of Biological Chemistry, vol. 279, no. 37, pp. 38448-38457
info:eu-repo/semantics/altIdentifier/pissn/0021-9258[print], 0021-9258[linking]
<